Rezolute Inc (RZLT)
4.135
-0.04
(-0.84%)
USD |
NASDAQ |
Jul 05, 14:02
Rezolute SG&A Expense (TTM): 13.97M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 13.97M |
December 31, 2023 | 13.07M |
September 30, 2023 | 13.36M |
June 30, 2023 | 12.18M |
March 31, 2023 | 11.60M |
December 31, 2022 | 10.75M |
September 30, 2022 | 10.00M |
June 30, 2022 | 9.356M |
March 31, 2022 | 8.878M |
December 31, 2021 | 8.535M |
September 30, 2021 | 8.494M |
June 30, 2021 | 7.907M |
March 31, 2021 | 6.767M |
December 31, 2020 | 6.379M |
September 30, 2020 | 5.405M |
June 30, 2020 | 6.071M |
March 31, 2020 | 6.475M |
December 31, 2019 | 7.064M |
September 30, 2019 | 7.155M |
June 30, 2019 | 6.865M |
March 31, 2019 | 7.252M |
December 31, 2018 | 7.784M |
September 30, 2018 | 8.348M |
June 30, 2018 | 9.10M |
March 31, 2018 | 10.33M |
Date | Value |
---|---|
December 31, 2017 | 9.822M |
September 30, 2017 | 9.298M |
June 30, 2017 | 8.229M |
March 31, 2017 | 6.327M |
December 31, 2016 | 5.780M |
September 30, 2016 | 5.509M |
June 30, 2016 | 5.503M |
March 31, 2016 | 5.641M |
December 31, 2015 | 5.245M |
September 30, 2015 | 5.205M |
June 30, 2015 | 5.997M |
March 31, 2015 | 6.832M |
December 31, 2014 | 7.416M |
September 30, 2014 | 6.564M |
June 30, 2014 | 5.136M |
March 31, 2014 | 3.921M |
December 31, 2013 | 6.357M |
September 30, 2013 | 6.195M |
June 30, 2013 | 5.998M |
March 31, 2013 | 4.786M |
December 31, 2012 | 0.8263M |
September 30, 2012 | 0.3459M |
June 30, 2012 | -0.1444M |
March 31, 2012 | 0.0858M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
5.405M
Minimum
Sep 2020
13.97M
Maximum
Mar 2024
9.128M
Average
8.535M
Median
Dec 2021
SG&A Expense (TTM) Benchmarks
Cytokinetics Inc | 169.45M |
Oragenics Inc | 5.999M |
GT Biopharma Inc | 7.409M |
IGM Biosciences Inc | 47.61M |
180 Life Sciences Corp | 8.241M |